Cite
Multiomics Integrative Analysis Identifying EPC1 as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma.
MLA
Dai, Yongmei, et al. “Multiomics Integrative Analysis Identifying EPC1 as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma.” BioMed Research International, Sept. 2022, pp. 1–15. EBSCOhost, https://doi.org/10.1155/2022/1074412.
APA
Dai, Y., Chen, W., Huang, J., Zheng, L., Lin, Q., Cui, T., & Huang, C. (2022). Multiomics Integrative Analysis Identifying EPC1 as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma. BioMed Research International, 1–15. https://doi.org/10.1155/2022/1074412
Chicago
Dai, Yongmei, Wenhan Chen, Junpeng Huang, Lijing Zheng, Qing Lin, Tongjian Cui, and Chen Huang. 2022. “Multiomics Integrative Analysis Identifying EPC1 as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma.” BioMed Research International, September, 1–15. doi:10.1155/2022/1074412.